Thrombolytic therapy in thrombosis.
D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009316:National Institutes of Health (U.S.); D011655:Pulmonary Embolism / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy*; D014481:United States
D005343:Fibrinolytic Agents